Aziyo Biologics Revenue and Competitors
Estimated Revenue & Valuation
- Aziyo Biologics's estimated annual revenue is currently $28.7M per year.
- Aziyo Biologics received $10.0M in venture funding in August 2018.
- Aziyo Biologics's estimated revenue per employee is $235,041
- Aziyo Biologics's total funding is $44.1M.
Employee Data
- Aziyo Biologics has 122 Employees.
- Aziyo Biologics grew their employee count by -10% last year.
Aziyo Biologics's People
Name | Title | Email/Phone |
---|---|---|
1 | Principal Scientist | Reveal Email/Phone |
Aziyo Biologics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is Aziyo Biologics?
Aziyo Biologics is a fully integrated, commercially oriented regenerative medicine company. Since its founding in 2015 the Company has expanded through acquisitions and strategic partnerships, creating a high growth commercial entity. Its proprietary products are used in orthopedic, cardiovascular and other medical specialties.
keywords:N/A$44.1M
Total Funding
122
Number of Employees
$28.7M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aziyo Biologics News
SILVER SPRING, Md., April 12, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine...
Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and...
SILVER SPRING, Md., March 31, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine...
Maryland’s health tech startup ecosystem is at it again. Silver Spring-based Aziyo Biologics Inc. has raised $10 million from seven investors in a funding round disclosed Tuesday in SEC filings. Founded in 2015, Aziyo is a private, commercially-oriented biotech company focused on regenerative ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $18.3M | 122 | 2% | N/A |
#2 | $25.6M | 122 | -4% | N/A |
#3 | $33.8M | 125 | -20% | N/A |
#4 | $28.6M | 126 | 18% | N/A |
#5 | $19.3M | 133 | 2% | N/A |
Aziyo Biologics Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2018-08-08 | $10.0M | Undisclosed | Mulitple | Article |